SANC00220



Urginin





C42H62O17

















8002-35-5



SMILES:

[H][C@@]8(O[C@@H]5C=C4CC[C@]2([H])[C@]([H])(CC[C@]3(C)[C@@H](c1ccc(=O)oc1)CC[C@]23O)[C@@]4(C)CC5)O[C@@H](C)[C@H](O[C@]6([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O[C@]7([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H]8O





References

  • Fusi et al. (2008) Vascular myorelaxing activity of isolates from South African Hyacinthaceae partly mediated by activation of soluble guanylyl cyclase in rat aortic ring preparations

  • Pohl et al. (2001) Bufadienolides from Drimia robusta and Urginea altissima (Hyacinthaceae)

  • Classifications

  • Bufadienolide

  • Steroid

  • Other Names

  • Bufa-4,20,22-Trienolide, 3-[(O-6-Deoxy-[Alpha]-L-Mannopyranosyl-(1[To]3)-O-[[Beta]-D-Glucopyranosyl-(1[To]4)]-6-Deoxy-[Alpha]-L-Mannopyranosyl)Oxy]-14-Hydroxy-, (3[Beta])-
  • Urginin
  • Urginin (8Ci)
  • Urginin Indica
  • 14[Beta]-Hydroxybufa-4,20,22-Trienolide 3[Beta]-O-{[Alpha]-L-Rhamnopyranosyl-[(1[To]4)-[Beta]-D-Glucopyranosyl]-(1[To]3)-[Alpha]-L-Rhamnopyranoside}

  • Source Organisms

  • Drimia altissima

    Compound Uses

  • Vascular myorelaxing activity